StockTipsArenaBeta

BUY Rossari Biotech Limited — Nirmal Bang Securities

BUYRossari Biotech Limited
Rossari Biotech share price target & all analyst calls

byNirmal Bang SecuritiesHorizon: NA (inferred 1 year)21 Oct 2026via ET Now (Live)

Entry₹436.5Inferred
Target₹680
Total upside +55.78%
Stop lossNot given
CMP₹416.910h ago
Active-4.49%+63.11%upside left 12 mo left
Follow Nirmal Bang Securities for new callsGet alertsWatch ROSSARI for new buy/sell callsGet alertsSee 6 other Long-term calls on ROSSARISee 160 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 22 Oct, 2:26 am IST
3 supporting1 neutral4 opposing
Supports the BUY call (3)

Rossari Biotech Shares May Rally Up To 56% Says Nirmal Bang After Q2 Results; Check Target Price

NewsNdtv-Profit·21 Oct · today

(opens in new tab)

3 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · same horizon·20 Oct · yesterday

Rossari Biotech reported record quarterly revenue of Rs 697.6 crore (up 19% YoY) and EBITDA of Rs 87 crore (up 20.9% YoY) for Q2 FY27, alongside plans for a new manufacturing facility in Saudi Arabia.

BSE · Company Update·19 Oct · 3d ago

(opens in new tab)
Neutral / worth noting (1)

Nothing found in this tip’s window yet.

Weighs against the BUY call (4)

Long-term trend bearish — 200-day average falling over the past quarter

Technicals · trend·21 Oct · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Rossari Biotech

All analyst calls on Rossari Biotech

More from Nirmal Bang Securities

Every call and its outcome